ANALYST RECOMMENDATIONS : Tesla, Nike, Netflix, Idexx Laboratories, Biogen...
Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.
- Biogen: Wedbush keeps neutral rating. PT down to $183 from $188.
- Comerica: Wedbush raises price target to $94 from $89, maintains outperform rating.
- Compass: Morgan Stanley downgrades to equalweight from overweight and lowers price target to $5 from $7.
- GSK Plc: Spin-Off Research downgrades to hold from buy. PT up 11% to $45.
- Henry Schein: Goldman Sachs cut the recommendation to neutral from buy. PT up 9% to $85.
- Hologic: BofA Securities lowers its price target to $75 from $81, to neutral from buy.
- Idexx Laboratories: Goldman Sachs raised to buy from neutral. PT up 13% to $435.
- L Brands: Goldman Sachs lowers price target to $32 from $37, maintains buy rating.
- Lululemon: Stifel adjusts price target to $381 from $500. Maintains buy rating.
- Jupiter Fund Management: Keefe, Bruyette & Woods moves to underperform from market perform with 121 pence.
- Mondi Plc: ABSA Securities downgrades to equal-weight from overweight. PT up 11% to 1,662.29 pence.
- Netflix: Credit Suisse maintains neutral rating. PT down to $263 from $360.
- Nike: Stifel maintains buy rating and price target down to $130 from $135.
- Nordstrom: KeyBanc starts at overweight with $30 price target.
- PVH Corp: Goldman Sachs downgrades to neutral from buy. PT down 6.9% to $59.
- Tapestry: Goldman Sachs adjusts price target to $35 from $39. Maintains neutral rating.
- Tesla: Goldman Sachs gives a buy rating. Price target set at USD 1000.
- Under Armour: Stifel cut the target to $10 from $13. Maintains hold rating.
By 
